Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNF-blocker Spacing in Rheumatoid Arthritis Remission (STRASS)
NCT00780793Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2008
- Primary completion
- Sep 2011
- Modality
- Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept, adalimumab in rheumatoid arthritis (RA), sponsored by Assistance publique - Hôpitaux de Paris. Started Sep 2008; status: completed.
02
Drugs
etanerceptadalimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00780793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00780793.